Evidence map›Paper›PMID 27558760›Full record

ArticleHealth services research2017

Medication Nonadherence: The Role of Cost, Community, and Individual Factors.

Ibrahim Abbass, Lee Revere, Jordan Mitchell, Ajit Appari

Abstract read
In one paragraph

Article in Health services research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ibrahim AbbassSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX.
Lee RevereSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX.
Jordan MitchellSchool of Business, University of Houston Clear Lake, League City, TX.
Ajit AppariSchool of Public Health, The University of Texas Health Science Center at Houston, Houston, TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explain the association of out-of-pocket (OOP) cost, community-level factors, and individual characteristics on statin therapy nonadherence. DATA SOURCES: BlueCross BlueShield of Texas claims data for the period of 2008-2011. STUDY

designA retrospective cohort of 49,176 insured patients, aged 18-64 years, with at least one statin refill during 2008-2011 was analyzed. Using a weighted proportion of days covered ratio, differences between adherent and nonadherent groups are assessed using chi-squared tests, t-tests, and a clustered generalized linear model with logit link function. PRINCIPAL

findingsStatin therapy adherence, measured at 48 percent, is associated with neighborhood-level socioeconomic factors, including race/ethnicity, educational attainment, and poverty level. Individual characteristics influencing adherence include OOP medication cost, gender, age, comorbid conditions, and total health care utilization.

conclusionsThis study signifies the importance of OOP costs as a determinant of adherence to medications, but more interestingly, the results suggest that other socioeconomic factors, as measured by neighborhood-level variables, have a greater association on the likelihood of adherence. The results may be of interest to policy makers, benefit designers, self-insured employers, and provider organizations.

Indexed as

Drug CostsFinancing, PersonalMedication AdherenceAdolescentAdultBlue Cross Blue Shield Insurance PlansFemaleHealth ServicesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInsurance Claim ReviewLinear ModelsMaleMiddle AgedRetrospective StudiesTexasHydroxymethylglutaryl-CoA Reductase Inhibitorscost sharinghealth care utilizationMedication adherenceout-of-pocket expense

Identifiers

PMID27558760
PMCPMC5517674

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.